Jun 14, 2022 / 03:00PM GMT
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity Analyst
Okay. All right. Well, good morning, everyone, and welcome to day 2 of the Goldman Sachs health care conference. I am Amit Hazan, the medical technology analyst at Goldman. And it's really nice to kick off day 2 with Geoff Martha of Medtronic and not a better way to kick it off really to have a conversation about everything going on with Medtronic. Always a lot going on. So Geoff, welcome and thank you so much. Very nice to do this with you in person.
Questions and Answers:
Amit Hazan - Goldman Sachs Group, Inc., Research Division - Equity AnalystI was reflecting back, I think when you got the CEO title, COVID hit. We were, I think, one of the first conferences you've attended virtually and had a good conversation with you just about what your thoughts were and you entered as difficult of a situation as one could imagine and have had to navigate through that for the last 2 years, it hasn't stopped. And so the first question has to be just reflecting on those 2 years, where you
Trustpilot
